1. Home
  2. OSCR vs IOVA Comparison

OSCR vs IOVA Comparison

Compare OSCR & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oscar Health Inc.

OSCR

Oscar Health Inc.

HOLD

Current Price

$13.23

Market Cap

4.1B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.97

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSCR
IOVA
Founded
2012
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Accident &Health Insurance
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
2.1B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
OSCR
IOVA
Price
$13.23
$3.97
Analyst Decision
Hold
Buy
Analyst Count
7
10
Target Price
$17.00
$9.11
AVG Volume (30 Days)
6.1M
16.9M
Earning Date
01-01-0001
05-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.84
EPS
N/A
N/A
Revenue
$11,701,427,000.00
N/A
Revenue This Year
$63.73
$49.14
Revenue Next Year
$5.40
$51.69
P/E Ratio
N/A
N/A
Revenue Growth
27.50
N/A
52 Week Low
$11.20
$1.64
52 Week High
$23.80
$5.63

Technical Indicators

Market Signals
Indicator
OSCR
IOVA
Relative Strength Index (RSI) 43.32 52.57
Support Level $12.47 $1.99
Resistance Level $15.11 $4.34
Average True Range (ATR) 0.68 0.50
MACD 0.00 -0.00
Stochastic Oscillator 34.12 28.72

Price Performance

Historical Comparison
OSCR
IOVA

About OSCR Oscar Health Inc.

Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: